Apogem Capital’s Tenet Healthcare THC Stock Holding History

Apogem Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,262	Closed	-$375K	–	110
2022 Q3	$375K	Buy	+7,262	New	+$431K	0.37%	87

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CCA

Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return

Apogem Capital's THC Position: Q4 2022 in Review

Apogem Capital sold out of Tenet Healthcare (THC) in Q4 2022, closing a stake of 7,262 shares — an estimated $375K sold.

Apogem Capital first reported a position in THC in Q3 2022 and held it in 1 quarter. The position peaked at $375K in Q3 2022. 355 funds tracked by Wall St. Rank hold THC as of Q4 2022.

Apogem Capital reported no remaining Tenet Healthcare position as of Q4 2022 after selling out during the quarter.
Apogem Capital sold 7,262 Tenet Healthcare shares in Q4 2022, an estimated $375K.
Apogem Capital first reported a position in Tenet Healthcare in Q3 2022 and held it in 1 quarter.
Apogem Capital's Tenet Healthcare position peaked at $375K in Q3 2022.
355 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.